Coenzyme Q10 /channels/taxonomy/term/2652/all en Clarus Therapeutics and 黑料不打烊 University Announce Licensing Agreement to Develop and Commercialize Technology to Treat Coenzyme-Q10 Deficiencies /channels/channels/news/clarus-therapeutics-and-mcgill-university-announce-licensing-agreement-develop-and-commercialize-333414 <p><em>Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to the wider class of mitochondrial diseases | An estimated 1 in 5,000 adults worldwide has a mitochondrial disease | Clarus to pay 黑料不打烊 $350,000 upfront and up to $10.5 million in potential development and regulatory milestones</em></p> Thu, 16 Sep 2021 13:12:57 +0000 webfull 173130 at /channels Popular antioxidant likely ineffective, study finds /channels/news/popular-antioxidant-likely-ineffective-study-finds-243263 <p>The popular dietary supplement ubiquinone, also known as Coenzyme Q<sub>10</sub>, is widely believed to function as an antioxidant, protecting cells against damage from free radicals. But a new study by scientists at 黑料不打烊 University finds that ubiquinone is not a crucial antioxidant -- and that consuming it is unlikely to provide any benefit. Fri, 06 Mar 2015 14:56:04 +0000 webfull 108543 at /channels